UBS Maintains Neutral on UiPath, Lowers Price Target to $15

Benzinga Newsdesk www.benzinga.com Negative 55.1%

Neg 55.1% Neu 0% Pos 0%

UBS analyst Radi Sultan maintains UiPath (NYSE:PATH) with a Neutral and lowers the price target from $19 to $15.

Comments

No comments yet. Be the first!